Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Viral Infections and Outbreaks Research, Influenza Virus Research Studies, and Immune Cell Function and Interaction.
Severe disease during both primary and secondary dengue virus infections in pediatric populations
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses
Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkey
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Influenza vaccine–induced human bone marrow plasma cells decline within a year after vaccination
Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans
Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model
Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans
Effector CD8 T cells dedifferentiate into long-lived memory cells
mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses
Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination
Human Ebola virus infection results in substantial immune activation
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy
Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
Activation of the RIG-I Pathway during Influenza Vaccination Enhances the Germinal Center Reaction, Promotes T Follicular Helper Cell Induction, and Provides a Dose-Sparing Effect and Protective Immunity
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines
Interleukin-21 Is a Critical Cytokine for the Generation of Virus-Specific Long-Lived Plasma Cells
Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8 <sup>+</sup> T-cell differentiation
<i>ZBTB32</i> Is an Early Repressor of the CIITA and MHC Class II Gene Expression during B Cell Differentiation to Plasma Cells